ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS - Patent 1054674

(19)

(11)

EP 1 054 674 A2

(12)

(88)	Date of publication A3:
	04.11.1999

(43)	Date of publication:
	29.11.2000 Bulletin 2000/48

(21)	Application number: 99907077.4

(22)	Date of filing: 17.02.1999

(51)	International Patent Classification (IPC)⁷: A61K 31/535, A61K 9/00, A61K 9/48, A61K 47/14

(86)	International application number:
	PCT/US9903/318

(87)	International publication number:
	WO 9940/921 (19.08.1999 Gazette 1999/33)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
	Designated Extension States:
	LT LV RO SI

(30)

Priority:

17.02.1998 US 74881 P

(71)	Applicant: Du Pont Pharmaceuticals Company
	Wilmington, DE 19807 (US)

(72)	Inventors:
	BAHAL, Surendra, M. Wayne, PA 19807 (US) MAURIN, Michael, B. Wilmington, DE 19810 (US)

(74)	Representative: Jones, Alan John et al
	CARPMAELS & RANSFORD43 Bloomsbury Square London, WC1A 2RA London, WC1A 2RA (GB)

(54)	ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS